These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595 [TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study. Burisch J; Weimers P; Pedersen N; Cukovic-Cavka S; Vucelic B; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Valpiani D; Boni MC; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Sanroman L; Almer S; Zhulina Y; Halfvarson J; Arebi N; Diggory T; Sebastian S; Lakatos PL; Langholz E; Munkholm P; J Crohns Colitis; 2014 Sep; 8(9):1030-42. PubMed ID: 24560877 [TBL] [Abstract][Full Text] [Related]
9. Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Burisch J; Vardi H; Pedersen N; Brinar M; Cukovic-Cavka S; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; OʼMorain C; Schwartz D; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Pineda JR; Almer S; Halfvarson J; Tsai HH; Sebastian S; Friger M; Greenberg D; Lakatos PL; Langholz E; Odes S; Munkholm P; Inflamm Bowel Dis; 2015 Jan; 21(1):121-31. PubMed ID: 25437816 [TBL] [Abstract][Full Text] [Related]
10. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Ng SC; Zeng Z; Niewiadomski O; Tang W; Bell S; Kamm MA; Hu P; de Silva HJ; Niriella MA; Udara WS; Ong D; Ling KL; Ooi CJ; Hilmi I; Lee Goh K; Ouyang Q; Wang YF; Wu K; Wang X; Pisespongsa P; Manatsathit S; Aniwan S; Limsrivilai J; Gunawan J; Simadibrata M; Abdullah M; Tsang SW; Lo FH; Hui AJ; Chow CM; Yu HH; Li MF; Ng KK; Ching JY; Chan V; Wu JC; Chan FK; Chen M; Sung JJ; Gastroenterology; 2016 Jan; 150(1):86-95.e3; quiz e13-4. PubMed ID: 26385074 [TBL] [Abstract][Full Text] [Related]
11. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I; Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448 [TBL] [Abstract][Full Text] [Related]
13. Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study. Vester-Andersen MK; Vind I; Prosberg MV; Bengtsson BG; Blixt T; Munkholm P; Andersson M; Jess T; Bendtsen F J Crohns Colitis; 2014 Dec; 8(12):1675-83. PubMed ID: 25154681 [TBL] [Abstract][Full Text] [Related]
14. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity. Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770 [TBL] [Abstract][Full Text] [Related]
15. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Vester-Andersen MK; Prosberg MV; Jess T; Andersson M; Bengtsson BG; Blixt T; Munkholm P; Bendtsen F; Vind I Am J Gastroenterol; 2014 May; 109(5):705-14. PubMed ID: 24642581 [TBL] [Abstract][Full Text] [Related]
16. Clinicians' adherence to international guidelines in the clinical care of adults with inflammatory bowel disease. Jackson BD; Con D; Liew D; De Cruz P Scand J Gastroenterol; 2017 May; 52(5):536-542. PubMed ID: 28128675 [TBL] [Abstract][Full Text] [Related]
17. Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Burisch J; Kiudelis G; Kupcinskas L; Kievit HAL; Andersen KW; Andersen V; Salupere R; Pedersen N; Kjeldsen J; D'Incà R; Valpiani D; Schwartz D; Odes S; Olsen J; Nielsen KR; Vegh Z; Lakatos PL; Toca A; Turcan S; Katsanos KH; Christodoulou DK; Fumery M; Gower-Rousseau C; Zammit SC; Ellul P; Eriksson C; Halfvarson J; Magro FJ; Duricova D; Bortlik M; Fernandez A; Hernández V; Myers S; Sebastian S; Oksanen P; Collin P; Goldis A; Misra R; Arebi N; Kaimakliotis IP; Nikuina I; Belousova E; Brinar M; Cukovic-Cavka S; Langholz E; Munkholm P; Gut; 2019 Mar; 68(3):423-433. PubMed ID: 29363534 [TBL] [Abstract][Full Text] [Related]